Latest Insider Transactions at Aim Immuno Tech Inc. (AIM)
This section provides a real-time view of insider transactions for Aim Immuno Tech Inc. (AIM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AIM ImmunoTech Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AIM ImmunoTech Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
60,110
+3.73%
|
$0
$0.18 P/Share
|
|
Sep 16
2024
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
5,000
+0.33%
|
$0
$0.3 P/Share
|
|
Sep 13
2024
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
20,000
+1.33%
|
$0
$0.31 P/Share
|
|
Sep 11
2024
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
312,500
+17.55%
|
$0
$0.32 P/Share
|
|
Aug 12
2024
|
Iii Peter W. Rodino COO, Secretary, Gen. Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
188,679
+31.98%
|
$0
$0.26 P/Share
|
|
Aug 12
2024
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
377,358
+24.62%
|
$0
$0.26 P/Share
|
|
May 06
2024
|
Iii Peter W. Rodino COO, Secretary, Gen. Counsel |
BUY
Open market or private purchase
|
Direct |
30,865
+12.68%
|
$0
$0.4 P/Share
|
|
May 06
2024
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
61,729
+7.35%
|
$0
$0.4 P/Share
|
|
Mar 21
2024
|
Nancy Bryan Director |
BUY
Open market or private purchase
|
Direct |
38,462
+50.0%
|
$0
$0.39 P/Share
|
|
Mar 15
2024
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
75,758
+9.56%
|
$0
$0.33 P/Share
|
|
Mar 15
2024
|
Iii Peter W. Rodino COO, Secretary, Gen. Counsel |
BUY
Open market or private purchase
|
Direct |
37,879
+17.25%
|
$0
$0.33 P/Share
|
|
Mar 15
2024
|
Stewart Appelrouth Director |
BUY
Open market or private purchase
|
Direct |
90,910
+27.49%
|
$0
$0.33 P/Share
|
|
Nov 27
2023
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
33,861
+5.02%
|
$0
$0.44 P/Share
|
|
Sep 29
2023
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
22,676
+3.6%
|
$0
$0.44 P/Share
|
|
Aug 25
2023
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
8,222
+1.39%
|
$0
$0.67 P/Share
|
|
Aug 24
2023
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
14,993
+2.54%
|
$0
$0.67 P/Share
|
|
Jul 17
2023
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
16,950
+2.93%
|
$0
$0.59 P/Share
|
|
Mar 10
2023
|
Stewart Appelrouth Director |
SELL
Other acquisition or disposition
|
Direct |
68,208
-31.42%
|
$68,208
$1.23 P/Share
|
|
Jan 03
2023
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
161,291
+22.87%
|
$0
$0.31 P/Share
|
|
Jan 03
2023
|
Iii Peter W. Rodino COO, Secretary, Gen. Counsel |
BUY
Open market or private purchase
|
Direct |
80,646
+35.92%
|
$0
$0.31 P/Share
|
|
Jan 03
2023
|
Stewart Appelrouth Director |
BUY
Open market or private purchase
|
Direct |
80,646
+27.09%
|
$0
$0.31 P/Share
|
|
Jul 18
2022
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
32,895
+7.92%
|
$0
$0.76 P/Share
|
|
Apr 25
2022
|
Stewart Appelrouth Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,500
+15.23%
|
$24,500
$1.07 P/Share
|
|
Apr 25
2022
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
49,020
+12.29%
|
$49,020
$1.02 P/Share
|
|
Apr 25
2022
|
Iii Peter W. Rodino COO, Secretary, Gen. Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,902
+7.2%
|
$4,902
$1.02 P/Share
|
|
Dec 13
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
21,552
+6.69%
|
$21,552
$1.16 P/Share
|
|
Dec 10
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
11,811
+4.06%
|
$11,811
$1.27 P/Share
|
|
Nov 24
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
11,627
+4.17%
|
$11,627
$1.29 P/Share
|
|
Nov 24
2021
|
Stewart Appelrouth Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,379
+14.76%
|
$19,379
$1.29 P/Share
|
|
Nov 23
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
11,194
+4.19%
|
$11,194
$1.34 P/Share
|
|
Nov 19
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
10,204
+4.0%
|
$10,204
$1.47 P/Share
|
|
Nov 17
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
9,146
+3.76%
|
$9,146
$1.64 P/Share
|
|
Jul 16
2021
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
15,625
+6.49%
|
$15,625
$1.92 P/Share
|
|
Feb 25
2021
|
Stewart Appelrouth Director |
BUY
Open market or private purchase
|
Direct |
10,638
+10.31%
|
$21,276
$2.35 P/Share
|
|
Feb 24
2021
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
11,062
+5.01%
|
$22,124
$2.26 P/Share
|
|
Dec 17
2020
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
14,535
+6.82%
|
$14,535
$1.72 P/Share
|